Clinical case of antiviral therapy in a patient with hepatitis C virus and rheumatoid arthritis

This article describes a clinical case of a patient with chronic viral hepatitis C and concomitant rheumatoid arthritis. The work is based on the study of the medical record of the patient with the diagnosis of "Chronic viral hepatitis C, genotype 1b" and the analysis of the course of the disease against the background of 12-week antiviral therapy, which led to the achievement of a sustainable viral response. As a result of the study of the presented clinical case, it can be concluded that, due to the similarity of symptoms, it is necessary to conduct a thorough differential diagnosis to distinguish between the debut of rheumatic disease and extrahepatic manifestations of HCV. The use of interferon drugs is limited in this category of patients due to side effects and poor tolerability, so pangenotypic therapy with Sofosbuvir and Velpatasvir has proven its effectiveness and safety in patients with rheumatoid arthritis and chronic viral hepatitis C.

Authors

Publication Details

Journal
Clinical review for general practice
Published
2025-01-26
DOI
https://doi.org/10.47407/kr2024.6.1.00549
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical case of antiviral therapy in a patient with hepatitis C virus and rheumatoid arthritis

А В Щербак, Elena Stilidi, Andrey V. Petrov, Ashime Sh. Asanova et al.
Clinical review for general practice
Hepatitis C virus research
article

Clinical case of antiviral therapy in a patient with hepatitis C virus and rheumatoid arthritis

А В Щербак, Elena Stilidi, Andrey V. Petrov, Ashime Sh. Asanova, lya S. Kapustin, Ludmila A. Semendyaeva, Igor A. Кurguzkin, Susanna R. Isliamova
article en

Abstract

This article describes a clinical case of a patient with chronic viral hepatitis C and concomitant rheumatoid arthritis. The work is based on the study of the medical record of the patient with the diagnosis of "Chronic viral hepatitis C, genotype 1b" and the analysis of the course of the disease against the background of 12-week antiviral therapy, which led to the achievement of a sustainable viral response. As a result of the study of the presented clinical case, it can be concluded that, due to the similarity of symptoms, it is necessary to conduct a thorough differential diagnosis to distinguish between the debut of rheumatic disease and extrahepatic manifestations of HCV. The use of interferon drugs is limited in this category of patients due to side effects and poor tolerability, so pangenotypic therapy with Sofosbuvir and Velpatasvir has proven its effectiveness and safety in patients with rheumatoid arthritis and chronic viral hepatitis C.

Clinical review for general practiceVol. 6(1)
Openalex Percentile: Top 84%
Hepatitis C virus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.